King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
about
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesNon invasive tools for the diagnosis of liver cirrhosis.A new scoring system for prediction of fibrosis in chronic hepatitis C.CUFA algorithm: assessment of liver fibrosis using routine laboratory data.Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis.Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link.Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study.A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients.HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre studyNon-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence.Recurrent HCV after liver transplantation-mechanisms, assessment and therapy.Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C.Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease.Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?Selected Noninvasive Markers in Diagnosing Liver Diseases.The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application.Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients.Usefulness of virtual touch quantification for staging liver fibrosis in patients with hepatitis C, and factors affecting liver stiffness measurement failure compared with liver biopsy.Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B
P2860
Q26779866-2CEBDE3F-1449-4E7D-9378-CB913869AE28Q26828855-C72B8D83-2D81-4AA3-B1E9-796F241F5DF3Q30421450-DB46B226-652F-4234-8550-09C4F7316C7FQ30472903-51189884-5401-4919-98EC-34C115CBA90EQ30834803-FE9644AF-387F-43EE-BB35-3C9D21756CCFQ30853941-B3B8E5C7-1214-499D-B40C-5ACA5EADA0A9Q34792158-6C570161-82FD-48FD-9A27-7DCBB35FABF9Q36052963-6232E4C2-9217-41CD-9A6C-9F3B120B163EQ36218142-14A9BB36-8D4E-4889-8EAA-F6AC606D1551Q36402864-AA4CC2F8-43B8-490F-AA73-9B5D05B78331Q37090659-11F21B43-E016-4FD6-8D88-EE8F0E1DC4E9Q37130289-F0E58F20-1CD5-415A-86A5-6C3F920DB6A6Q37182242-AA50768D-BBF6-4AC1-AA72-24D2EFDA20E6Q37868672-C9437C0F-94AD-4050-8893-B4AA89C4B183Q38229320-05C4C2D6-4A03-4893-A3C8-1A509EA2DD8EQ38618343-E2B7AD5A-4F68-4A2C-82C6-F681A96E7575Q38863591-97291FB0-EC5B-48D9-8966-A407282328D1Q39256947-8050D2A0-0942-4C98-AF96-811ED6784F76Q40121899-FECC1129-7173-4004-8DC9-DE02DA652ABEQ40852299-1D8E5A50-8E75-48F3-84B3-DEFAFAC48B06Q41112075-85AB35B8-68EF-4D4F-B70F-1E82368F7C10Q42223904-8E4A1C5D-6A39-4557-B9B2-F2DA3A2C55A5Q43210156-78ED530D-7919-42DD-89E4-28438C7CBB9FQ43239556-FF9DAD54-E71E-48B8-B1D6-DD984C833959Q44887130-F2C51062-F484-4A1B-9C8B-C063D5F34615Q47567320-E12D1393-73F2-41DE-B75F-E5D82AC72CF1Q47654061-60772F2A-6C28-463A-8228-6E328028EA72Q49850164-B61023B2-0017-4B14-8B51-12239C2A5620Q50041788-03686925-1BC3-4361-A70A-CB1705F25DD3Q55092099-2E255DE4-13E9-4FCF-9220-7F63A8A351A0Q58551532-B7D65E2D-A126-4290-BB55-5F86BEFEC501
P2860
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@en
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@nl
type
label
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@en
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@nl
prefLabel
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@en
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@nl
P2093
P1476
King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
@en
P2093
Bernard Portmann
Matthew Bruce
Paolo Rizzi
Philip A Berry
Phillip M Harrison
Timothy J S Cross
P304
P356
10.1097/MEG.0B013E32830DFCB3
P577
2009-07-01T00:00:00Z